Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Avricore Health (AVCRF) Return on Sales (2016 - 2025)

Historic Return on Sales for Avricore Health (AVCRF) over the last 17 years, with Q3 2025 value amounting to 10.04%.

  • Avricore Health's Return on Sales fell 98900.0% to 10.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year decrease of 4600.0%. This contributed to the annual value of 0.03% for FY2024, which is 2300.0% up from last year.
  • As of Q3 2025, Avricore Health's Return on Sales stood at 10.04%, which was down 98900.0% from 16.38% recorded in Q2 2025.
  • Avricore Health's 5-year Return on Sales high stood at 0.14% for Q1 2024, and its period low was 16.38% during Q2 2025.
  • In the last 5 years, Avricore Health's Return on Sales had a median value of 0.32% in 2022 and averaged 2.59%.
  • Per our database at Business Quant, Avricore Health's Return on Sales soared by 87200bps in 2022 and then tumbled by -164400bps in 2025.
  • Quarter analysis of 5 years shows Avricore Health's Return on Sales stood at 3.78% in 2021, then skyrocketed by 94bps to 0.24% in 2022, then soared by 121bps to 0.05% in 2023, then rose by 27bps to 0.07% in 2024, then tumbled by -15524bps to 10.04% in 2025.
  • Its last three reported values are 10.04% in Q3 2025, 16.38% for Q2 2025, and 0.17% during Q1 2025.